A hypothesis: Radiation-related leukemia is mainly attributable to the small number of people who carry pre-existing clonally expanded preleukemic cells

Radiation Research

Volumn 163, Issue 3, 2005, Pages 258-265

  Nakamura, Nori ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CANCER RISK; CELL CLONE; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; DNA DAMAGE; GENOME; HUMAN; LEUKEMIA; LEUKEMIA CELL; PRELEUKEMIA; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION SICKNESS;

CHROMOSOME ABERRATIONS; DNA DAMAGE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, RADIATION-INDUCED; MALE; NUCLEAR WARFARE; TIME FACTORS; TRANSLOCATION, GENETIC;

EID: 14344260855     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3311     Document Type: Article

References (45)

1. D. L. Preston, S. Kusumi, M. Tomonaga, S. Izimi, E. Ron, A. Kuramoto, N. Kamada, H. Dohy and K. Mabuchi, Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiol Res. 137 (Suppl.), S68-S97 (1994).
2. R. Doll and R. Wakeford, Risk of childhood cancer from fetal irradiation. Br. J. Radiol. 70, 130-139 (1997).
3. J. F. Bithell and A. M. Stewart, Pre-natal irradiation and childhood malignancy: A review of British data from the Oxford Survey. Br. J. Cancer 31, 271-287 (1975).
4. E. S. Jaffe, N. L. Harris, H. Stein and J. W. Vardiman, Pathology and Genetics of Tumors of Haematopoitic and Lymphoid Tissues. IARC Press, Lyon, 2001.
5. Y. Kodama, D. Pawel, N. Nakamura, D. Preston, T. Honda, M. Itoh, M. Nakano, K. Ohtaki, S. Funamoto and A. A. Awa, Stable chromosome aberrations in atomic bomb survivors: Results from 25 years of investigation. Radiat. Res. 156, 337-346 (2001).
6. D. C. Lloyd, R. I. Purrott, G. W. Dolphin, D. Bolton, A. A. Edwards and M. J. Corp, The relationship between chromosome aberrations and low LET radiation dose to human lymphocytes. Int. J. Radiol Biol. 28, 75-90 (1975).
7. T. Ito, T. Seyama, T. Mizuno, T. Hayashi, K. S. Iwamoto, K. Dohi, N. Nakamura and M. Akiyama, Induction of BCR-ABL fusion genes by in vitro X-irradiation. Jpn. J. Cancer Res. 84, 105-109 (1993).
8. T. Mizuno, K. S. Iwamoto, S. Kyoizumi, H. Nagamura, T. Shinohara, K. Koyama, T. Seyama and K. Hamatani, Preferential induction of RET/PTC1 rearrangement by X-ray irradiation. Oncogene 19, 438-443 (2000).
9. M. F. Greaves and J. Wiemels, Origins of chromosome translocations in childhood leukaemia. Nat. Rev. Cancer 3, 639-649 (2003).
10. M. N. Cornforth, K. M. Greulich-Bode, B. D. Loucas, J. Arsuaga, M. Vazquez, R. K. Sachs, M. Bruckner, M. Molls, P. Hahnfeldt and D. J. Brenner, Chromosomes are predominantly located randomly with respect to each other in interphase human cells. J. Cell Biol. 159, 237-244 (2002).
11. J. H. Folley, W. Borges and T. Yamawaki, Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am. J. Med. 13, 311-321 (1952).
12. M. Nakanishi, K. Tanaka, T. Shintani, T. Takahashi and N. Kamada, Chromosome instability in acute myelocytic leukemia and myelodysplasic syndrome patients among atomic bomb survivors. J. Radiat. Res. 40, 159-167 (1999).
13. D. M. Parkin, S. L. Whelan, J. Ferlay, L. Teppo and D. B. Thomas, Eds., Cancer Incidence in Five Continents, Vol. VIII. Scientific Publication No. 155, IARC, Lyon, 2002.
14. C. A. Felix and B. J. Lange, Leukemia in infants. Oncologist 4, 225-240 (1999).
15. L. M. Seeker-Walker, H. G. Prentice, J. Durrant, S. Richrad, E. Hall and G. Harrison, Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukemia on MRC trial UKALL XA. Br. J. Haematol. 96, 601-610 (1997).
16. H. Mori, S. M. Colman, Z. Xiao, A. M. Ford, L. E. Healy, C. Donaldson, J. M. Hows, C. Navarrete and M. Greaves, Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl. Acad. Sci. USA 99, 8242-8247 (2002).
17. P. Andreasson, J. Schwaller, E. Anastasiadou, J. Aster and D. G. Gilliland, The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet. Cytogenet. 130, 93-104 (2001).
18. M. Eguchi-Ishimae, M. Eguchi, E. Ishii, S. Miyazaki, K. Ueda, N. Kamada and S. Mizutani, Breakage and fusion of the TEL(ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood 97, 737-743 (2001).
19. L. D. Cooley, D. A. Sears, M. M. Udden, W. R. Harrison and K. R. Baker, Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am. J. Hematol. 63, 46-53 (2000).
20. M. A. Kadhim, S. J. Marsden and E. G. Wright, Radiation-induced chromosomal instability in human fibroblasts: Temporal effects and influence of radiation quality. Int. J. Radiat. Biol. 73, 143-148 (1998).
21. M. Nakano, Y. Kodama, K. Ohtaki, M. Itoh, A. A. Awa, J. Cologne, Y. Kusunoki and N. Nakamura, Estimation in the number of hematopoietic stem cells giving rise to clonal chromosome aberrations in blood T lymphocytes. Radiat. Res. 161, 273-281 (2004).
22. N. Nakamura, M. Nakano, Y. Kodama, K. Ohtaki, J. Cologne and A. A. Awa, Prediction of clonal chromosome aberration frequency in human blood lymphocytes. Radiat. Res. 161, 282-289 (2004).
23. C. A. Felix, Leukemias related to treatment with DNA topoisomerase II inhibitors. Med. Pediatr. Oncol. 36, 525-535 (2001).
24. A. Borkhardt, G. Cazzaniga, S. Viehmann, M. G. Valsecchi, W. D. Ludwig, L. Burci, S. Mangioni, M. Schrappe, H. Riehm and A. Biondi, Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood 90, 571-577 (1997).
25. A. A. Ferrando, D. S. Neuberg, J. Staunton, M. L. Loh, C. Huard, S. C. Raimondi, F. G. Behm, C. H. Pui, J. R. Downing and A. T. Look, Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75-87 (2002).
26. E. R. Panzer-Grumayer, K. Fasching, S. Panzer, K. Hettinger, K. Schmitt, S. Stockler-Ipsiroglu and O. A. Haas, Nondisjunction of chromosomes leading to hyperdiploid childhood B-cell precursor acute lymphoblastic leukemia is an early event during leukemogenesis. Blood 100, 347-349 (2002).
27. J. W. Taub, M. A. Konrad, Y. Ge, J. M. Naber, J. S. Scott, L. H. Matherly and Y. Ravindranath, High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood 99, 2992-2996 (2002).
28. W. A. Gilman, G. W. Knearle, E. G. Knox and A. M. Stewart, Pregnancy x-rays and childhood cancers: Effects of exposure age and radiation dose. J. Radiat. Prot. 8, 3-8 (1988).
29. M. Vickers, Estimation of the number of mutations necessary to cause chronic myeloid leukaemia from epidemiological data. Br. J. Haematol. 94, 1-4 (1996).
30. C. Biernaux, M. Loos, A. Sels, G. Huez and P. Stryckmans, Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86, 3118-3122 (1995).
31. S. Bose, M. Deininger, J. Gora-Tybor, J. M. Goldman and J. V. Melo, The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease. Blood 92, 3362-3367 (1998).
32. M. Vickers, G. Jackson and P. Taylor, The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation. Leukemia 14, 722-726 (2000).
33. J. A. Martinez-Climent, M. J. Thirman, R. Epstein, III, M. M. Le Beau and J. D. Rowley, Detection of 11q23/MLL rearrangements in infant leukemia with fluorescence in situ hybridization and molecular analysis. Leukemia 9, 1299-1304 (1995).
34. J. A. Ross, Dietary flavonoids and MLL gene: A pathway to infant leukemia? Proc. Natl. Acad. Sci. USA 97, 4411-4413 (2000).
35. R. Strick, P. L. Strissel, S. Borgers, S. L. Smith and J. D. Rowley, Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. USA 97, 4790-4795 (2000).
36. D. L. Preston, Y. Shimizu, D. A. Pierce, A. Suyama and K. Mabuchi, Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 160, 381-407 (2003).
37. A. V. Moorman, E. Roman, R. A. Cartwright and G. J. Morgan, Age-specific incidence rates for cytogenetically-defined subtypes of acute myeloid leukemia. Br. J. Cancer 86, 1061-1063 (2002).
38. C. Schoch, W. Kern, P. Krawitz, M. Dugas, S. Schnittger, T. Haferlach and W. Hiddemann, Dependence of age-specific incidence of acute myeloid leukemia on karyotype. Blood 98, 3500 (2001).
39. D. A. Pierce and M. L. Mendelsohn, A model for radiation-related cancer suggested by atomic bomb survivor data. Radiat. Res. 152, 642-654 (1999).
40. J. Thacker and R. Cox, Mutation induction and inactivation in mammalian cells exposed to ionizing radiation. Nature 258, 429-431 (1975).
41. Vijayalaxmi and H. J. Evans, Measurement of spontaneous and X-irradiation-induced 6-thioguanine-resistant human blood lymphocytes using a T-cell cloning technique. Mutat. Res. 125, 87-94 (1984).
42. B. J. Sanderson, J. L. Dempsey and A. A. Morley, Mutations in human lymphocytes: Effect of X- and UV-irradiation. Mutat. Res. 140, 223-227 (1984).
43. K. S. Iwamoto, T. Mizuno, T. Ito, M. Akiyama, N. Takeichi, K. Mabuchi and T. Seyama, Feasibility of using decades-old archival tissues in molecular oncology/epidemiology. Am. J. Pathol. 149, 399-406 (1996).
44. Y. Matsumoto, K. Nomura, S. Matsumoto, K. Ueda, M. Nakao, K. Nishida, H. Sakabe, S. Yokota, S. Horiike and M. Taniwaki, Detection of t(14;18) in follicular lymphoma by dual-color fluorescence in situ hybridization on paraffin-embedded tissue sections. Cancer Genet. Cytogenet. 150, 22-26 (2004).
45. Y. Yuan, L. Zhou, T. Miyamoto, H. Iwasaki, N. Harakawa, C. J. Hetherington, S. A. Burel, E. Lagasse, I. L. Weissman and D. E. Zhang, AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc. Natl. Acad. Sci. USA 98, 10398-10403 (2001).